DE69901051D1 - Zusammensetzungen, die einen Guggul-Extrakt mit Phosphatsalzen enthalten - Google Patents
Zusammensetzungen, die einen Guggul-Extrakt mit Phosphatsalzen enthaltenInfo
- Publication number
- DE69901051D1 DE69901051D1 DE69901051T DE69901051T DE69901051D1 DE 69901051 D1 DE69901051 D1 DE 69901051D1 DE 69901051 T DE69901051 T DE 69901051T DE 69901051 T DE69901051 T DE 69901051T DE 69901051 D1 DE69901051 D1 DE 69901051D1
- Authority
- DE
- Germany
- Prior art keywords
- phosphate
- guggul extract
- composition
- compositions containing
- phosphate salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/179,328 US6113949A (en) | 1998-10-27 | 1998-10-27 | Weight control product and method of treating hyperlipidemia and increasing vigor with said product |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69901051D1 true DE69901051D1 (de) | 2002-04-25 |
Family
ID=22656113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69901051T Expired - Lifetime DE69901051D1 (de) | 1998-10-27 | 1999-10-27 | Zusammensetzungen, die einen Guggul-Extrakt mit Phosphatsalzen enthalten |
Country Status (6)
Country | Link |
---|---|
US (1) | US6113949A (de) |
EP (1) | EP0997149B1 (de) |
AT (1) | ATE214613T1 (de) |
CA (1) | CA2267488A1 (de) |
DE (1) | DE69901051D1 (de) |
GB (1) | GB2343115A (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6896901B2 (en) * | 2000-12-22 | 2005-05-24 | Council Of Scientific & Industrial Research | Method of treating a cognitive memory dysfunction using Gugulipid |
US6485710B2 (en) * | 2000-12-27 | 2002-11-26 | Arthur Zuckerman | Appetite suppressant toothpaste |
US6610277B2 (en) * | 2000-12-27 | 2003-08-26 | Arthur Zuckerman | Appetite suppressant toothpaste |
EP1238590A1 (de) * | 2001-03-09 | 2002-09-11 | Unilever N.V. | Nahrungsmittelprodukt auf der Basis von Fett |
AU2002344160A1 (en) * | 2001-05-29 | 2002-12-09 | Unilever Plc | Food compositions for reducing insulin resistance |
US6849278B2 (en) * | 2001-11-21 | 2005-02-01 | Universal Biotech Co., Ltd. | Method to counter oxidation of LDL, decrease triglyceride or cholesterol and inhibit atherosclerosis using Hibiscus sabdariffa extract |
US6852342B2 (en) | 2002-03-26 | 2005-02-08 | Avoca, Inc. | Compounds for altering food intake in humans |
WO2003090673A2 (en) * | 2002-04-22 | 2003-11-06 | Rtc Research & Development, Llc. | Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals |
WO2003092614A2 (en) * | 2002-05-02 | 2003-11-13 | Hickle Randall S | Lipid removal from the body |
US6565896B1 (en) * | 2002-07-03 | 2003-05-20 | Vitacost.Com, Inc. | Cholesterol treatment formulation |
US20040253327A1 (en) * | 2003-06-12 | 2004-12-16 | Niazi Sarfaraz K. | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides, and sugar and preventing or treating cardiovascular diseases |
US20050025844A1 (en) * | 2003-08-02 | 2005-02-03 | Matthias Boldt | Weight control compositions and methods |
US20050163872A1 (en) * | 2004-01-23 | 2005-07-28 | Cargill, Incorporated | Compositions and methods for reducing cholesterol |
WO2006017211A1 (en) * | 2004-07-12 | 2006-02-16 | Research Development Foundation | Guggulsterone as an inhibitor of nuclear factor-kb and ikbalpha kinase activation |
FR2876912B1 (fr) * | 2004-10-25 | 2007-04-20 | Nuxe Sa Lab | Nouvelle utilisation de guggulipides en therapeutique et en cosmetique |
DE602005018384D1 (de) * | 2004-10-22 | 2010-01-28 | Nuxe Lab | Neuartige verwendung von chaulmoogra-öl und guggulipiden in therapeutika und kosmetika |
US8287924B2 (en) | 2011-03-17 | 2012-10-16 | Sonia Pharma Gmbh | Treatment of menopausal symptoms as novel indication for myrrh |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4117120A (en) * | 1977-02-11 | 1978-09-26 | Elderbaum Gilbert J | Medication for herpes simplex and canker sores |
US4364922A (en) * | 1980-10-14 | 1982-12-21 | University Of Virginia Alumni Patents Foundation | Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances |
US4592912A (en) * | 1983-10-31 | 1986-06-03 | Harriet Nickolaus | Ache and pain relieving and preventing composition |
US4719111A (en) * | 1985-06-14 | 1988-01-12 | Wilson Lynn M | Novel composition for treatment of decubitus ulcers |
US4713242A (en) * | 1985-11-07 | 1987-12-15 | Tecma Laboratories, Inc. | Skin therapeutic mixture containing eupatorium extract |
US4847071A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US4847069A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
US5011843A (en) * | 1988-05-31 | 1991-04-30 | Iolab Corporation | Treatment of glaucoma using phosphodiesterase inhibitors |
DK339289D0 (da) * | 1989-07-07 | 1989-07-07 | Dak Lab As | Farmaceutisk praeparat |
JPH0366623A (ja) * | 1989-08-03 | 1991-03-22 | Toreede Uindo Kk | 肥満防止剤及びその製造法 |
EP0447706A1 (de) * | 1990-03-22 | 1991-09-25 | Cipla Limited | Verfahren zur Herstellung einer pharmazeutischen aktiven Mischung der Guggulsteronen Z und E |
IT1247933B (it) * | 1991-05-15 | 1995-01-05 | Indena Spa | Estratti di commiphora mukul e loro applicazioni terapeutiche |
US5238965A (en) * | 1991-05-31 | 1993-08-24 | The Procter & Gamble Company | Methods of using lysophosphatidic acids for regulating skin wrinkles |
US5104676A (en) * | 1991-06-27 | 1992-04-14 | Abbott Laboratories | Weight control product |
WO1993010756A1 (en) * | 1991-11-25 | 1993-06-10 | Richardson-Vicks, Inc. | Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
CA2159985C (en) * | 1993-04-20 | 1999-07-13 | Raphael Warren | Methods of using hesperetin for sebum control and treatment of acne |
US5494668A (en) * | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
JP3396542B2 (ja) * | 1994-07-22 | 2003-04-14 | 株式会社成幸社 | 固形上の痩身用食品 |
US5690948A (en) * | 1997-01-10 | 1997-11-25 | Elizabeth Arden Co., Division Of Conopco, Inc. | Antisebum and antioxidant compositions containing guguliped and alcoholic fraction thereof |
-
1998
- 1998-10-27 US US09/179,328 patent/US6113949A/en not_active Expired - Lifetime
-
1999
- 1999-03-29 GB GB9907037A patent/GB2343115A/en not_active Withdrawn
- 1999-03-30 CA CA002267488A patent/CA2267488A1/en not_active Abandoned
- 1999-10-27 EP EP99308490A patent/EP0997149B1/de not_active Expired - Lifetime
- 1999-10-27 DE DE69901051T patent/DE69901051D1/de not_active Expired - Lifetime
- 1999-10-27 AT AT99308490T patent/ATE214613T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0997149B1 (de) | 2002-03-20 |
US6113949A (en) | 2000-09-05 |
EP0997149A1 (de) | 2000-05-03 |
ATE214613T1 (de) | 2002-04-15 |
GB9907037D0 (en) | 1999-05-19 |
GB2343115A (en) | 2000-05-03 |
CA2267488A1 (en) | 2000-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69901051D1 (de) | Zusammensetzungen, die einen Guggul-Extrakt mit Phosphatsalzen enthalten | |
DE69124223T2 (de) | Vitamine und mineralien enthaltende nahrungszusätze | |
Basu et al. | Intestinal absorption in health and disease: micronutrients | |
Harker et al. | Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. | |
Felsenfeld et al. | Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: a hypothesis to integrate a historical and modern perspective | |
WO2002002190A3 (en) | Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes | |
DE69122099D1 (de) | Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen | |
NO20063328L (no) | Anvendelse av en fettsyresammensetning som innbefatter minst en av EPA og DHA eller kombinasjoner derav | |
NZ541593A (en) | Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis | |
EP0852117A4 (de) | Wirkstoffe zum verbesserten fettstoffwechsel | |
CA2078019A1 (en) | Substance or composition and uses thereof | |
Nair et al. | Impact evaluation of iron & iodine fortified salt | |
AU5916998A (en) | Non-irritating composition for treating acne and other skin conditions | |
MY134314A (en) | Alertness bar | |
Fullmer | Intestinal calcium and lead absorption: effects of dietary lead and calcium | |
BG100911A (en) | Biophosphonic acids-sontaining wet-granulated form | |
ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
WO2003020233A3 (de) | Stabilisierung uv-empfindlicher wirkstoffe | |
ATE271392T1 (de) | Lipoproteinkomplexe und zusammensetzungen, die diese enthalten | |
BRPI0309421A8 (pt) | Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia | |
WO2001005356A3 (en) | Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant | |
ATE238805T1 (de) | Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält | |
de Jong et al. | Hyperhomocysteinemia and atherothrombotic disease | |
JP2020528888A (ja) | 心血管器官の病態の予防及び処置における使用のための組成物 | |
GB2210789A (en) | Topical application for skin care |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |